IDEXX amends credit agreement, extends revolver to five years and adds $250 million term loan
On November 12, 2025, IDEXX Laboratories and its subsidiaries entered into Amendment No. 2 to its credit agreement with JPMorgan Chase Bank as administrative agent. The amendment extends the maturity of the $1.0 billion unsecured revolving credit facility to five years and provides for a term loan facility maturing in three years, giving the company longer-dated borrowing capacity. The filing does not state any amount drawn under the facilities.
Key points
- Revolving credit facility of $1.0 billion extended to five years from the amendment closing date.
- New term loan facility maturing three years from the closing date; the existing $250 million unsecured term loan is also referenced.
- Credit agreement includes flexibility for up to $250 million in incremental revolving commitments and/or term loans.
- Interest is priced at SOFR, CORRA, EURIBOR or other benchmark rates plus margins of 0.0% to 1.375% based on the consolidated leverage ratio.
The filing
Written by AI on Nov 8, 2026, 1:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 13, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.